IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 41901 - 41925 of 46108

News & Analysis

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

09 October 2018 by GSK

The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.
News & Analysis

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2020

07 October 2020 by GSK

The Chinese Outbound Investment Guide 2020 has been published by the International Financial Law Review (IFLR) looking at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.
News & Analysis

2019 M&A Report: Luxembourg

01 March 2019 by Marcus Peter, GSK Stockmann (Luxembourg)

2018 has once again shown a growing trend in M&A transactions with a view to Luxembourg-based target entities as well as acquisitions outside of Luxembourg that were started using a Luxembourg structure. Luxembourg-based targets are typically not the centre of high-profile M&A targets.
News & Analysis

IFLR 2018 M&A Report: Luxembourg

19 December 2018 by GSK Stockmann

IFLR 2018 M&A Report: Luxembourg
News & Analysis

GSK Stockmann appoints its first International Partner and elects new co-Managing Partner

12 December 2018 by GSK

At the end of November 2018, GSK Stockmann’s Partners elected Andreas Heinzmann as International Partner and Dr. Uwe Jäger as new co-Managing Partner. These nominations underpin GSK’s commitment to internationaliza-tion and the consistent implementation of the modernization course the firm set out on.
News & Analysis

GSK Stockmann advised on the first real blockchain securities transaction

25 March 2019 by GSK

In mid-January 2019, GSK Stockmann advised on Germany’s first-ever issuance of securities originally carried out as a blockchain transaction. Commerzbank AG, Continental AG and Siemens AG were involved in the transaction.
News & Analysis

GSK Stockmann and DCU Brexit Institute announce partnership

10 September 2020 by GSK

GSK Stockmann in Luxembourg and DCU Brexit Institute announce a partnership which will see GSK Stockmann become a new sponsor of the Institute. GSK Stockmann will support the core activities of the Brexit Institute, including its research and policy work on the relations between the EU and the UK post withdrawal and the future of Europe more generally.
News & Analysis

GSK Stockmann in Luxembourg advises China Merchants Bank on its launch of their first European-based investment fund

04 January 2019 by GSK

GSK Stockmann’s Luxembourg office has advised China Merchants Bank (CMB) on its launch of CMB Evergreen SA, SICAV-SIF, a Luxembourg investment fund and being the first European-based investment fund of CMB.
News & Analysis

Mathilde Ostertag appointed as new president of Ladies In Law Luxembourg Association (LILLA)

24 July 2019 by GSK

Mathilde Ostertag, Partner at GSK Stockmann Luxembourg, has been appointed as new president of LILLA – Ladies In Law Luxembourg Association. LILLA is the first network of its kind for women working within the legal sector in Luxembourg and was founded two years ago.

News & Analysis

GSK Stockmann advises Starwood Capital Group and Cells on Purchasing the Office Buildings Fifty Avon in Frankfurt

13 September 2018 by GSK

The joint venture of a Starwood Capital Group fund subsidiary and CELLS Property Investors bought the Fifty Avon office buildings in downtown Frank-furt in a share deal. GSK Stockmann provided the legal support for this trans-action. The parties agreed to keep the purchase price confidential.
News & Analysis

Highway to the debt zone

08 December 2020 by GSK

Following a decade of unprecedented growth worldwide, debt capital markets continue to boom. Innovative investment vehicles emerge, structured finance and securitisation capabilities expand and new routes for funding the real economy develop. Driven by a regulatory wave and historic low interests, the industry has gone through transformative changes over the last few decades and is now playing a key role in the Capital Markets Union, the European Commission’s action plan for a more inclusive and resilient economy.
News & Analysis

GSK Stockmann in Luxembourg advises EQT regarding the merger of Sivantos and Widex to create global hearing aid leader

17 May 2018 by GSK

GSK Stockmann’s Luxembourg office is advising EQT pertaining to the merger of the two leading hearing aid companies. With a comprehensive, multi-channel sales and distribution platform in more than 125 markets and combined revenues of approximately EUR 1.6 billion the new hearing aid company will become a top-three contender globally.
News & Analysis

GSK Stockmann advises Corestate Capital Group on the acquisition of five major real estate projects

12 January 2018 by GSK

GSK Stockmann provided legal counsel to Corestate Capital Group on the acquisition of a package of five large-scale projects with a residential focus in a forward (asset) deal. The five objects were acquired for the real estate umbrella fund launched by Universal-Investment on behalf of the Bayrische Versorgungskammer on its Luxembourg-based AIF platform. Seller is the project developer CG Gruppe AG.
News & Analysis

GSK Stockmann in Luxembourg certified as Great Place to Work

11 January 2021 by GSK

GSK Stockmann in Luxembourg has been certified as Great Place to Work® for 2020-2021 based on an anonymous online survey with more than 60 questions conducted by the Great Place to Work® Institute. As a result of the study, the trust index shows that 94 % of the employees say that GSK Stockmann in Luxembourg is a Great Place to Work
News & Analysis

Guidelines on performance fees – What are the consequences for fund managers?

17 November 2020 by GSK

In return for a positive performance of the portfolio management function, investment fund managers frequently charge a performance fee to the investment funds they manage. In this respect, discussions have taken place, also involving national financial supervisory authorities, about the balance between such performance fee and investor protection rules. As a consequence, the European Securities and Markets Authority (“ESMA”) reviewed current performance fee models and recently issued final guidelines for the purpose of harmonizing the interests of fund managers and investors, which apply from 6 January 2021.
News & Analysis

GSK Stockmann contributed to the publication of The International Comparative Legal Guide to Real Estate 2021

05 January 2021 by GSK

The 16th edition of The International Comparative Legal Guide to: Real Estate has been published by the Global Legal Group providing cross-border insight into real estate law.
News & Analysis

Luxembourg: A growth outlook in a new reality

04 November 2020 by GSK

Q&A with Marcus Peter and Irina Stoliarova discussing the key trends currently driving growth and development within Luxembourg’s funds industry.
Firm

Van Doorne - Netherlands

Practice areas

Banking, Capital markets : Debt, Capital markets : Equity, Financial and corporate, M&A, Project finance, Restructuring and insolvency

News & Analysis

Luxembourg: New partner in Luxembourg: GSK Stockmann brings Anna Gassner on board

02 October 2023 by GSK Stockmann - Luxembourg

Anna Gassner will be joining GSK Stockmann’s team in Luxembourg as of 1 October 2023. The addition of a new partner is part of the firm’s strategy to further expand its advisory services in the areas of corporate M&A and private equity.
Lawyer

Mark Moolhuizen

Practice areas

PPP/PFI, Project finance

Industry sectors

Real estate

Lawyer

Onno Boerstra

Practice areas

M&A, Private equity

Industry sectors

Financial services

Lawyer

Roel Botter

Practice areas

Asset finance, Capital markets, Project finance

News & Analysis

GSK Stockmann promotes fourteen lawyers from their own ranks

16 November 2020 by GSK

On the occasion of their partner meeting on 13th/14th November, GSK Stockmann appointed three new Equity Partners, nine Local Partners and two Counsel from their own ranks. In doing so, the law firm continues to pursue its (inter)national growth targets even during Corona’s challenging times, focussing above all on the development and encouragement of its own up-and-coming legal talents.
Firm

SSW Spaczyński, Szczepaniak i Wspólnicy - Poland

Practice areas

Banking, Capital markets : Debt, Capital markets : Equity, Financial and corporate, M&A, Project development : Infrastructure, Project development : Power, Project finance

Lawyer

Piotr Spaczyński

Practice areas

Project development

Industry sectors

Energy, Mining, Natural resources

Load more